Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide

類似資料

• Prognostic value of test(s) for O(6)‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
  著者:: McAleenan, Alexandra, 等
  出版事項: (2019)
• Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma
  著者:: McAleenan, Alexandra, 等
  出版事項: (2019)
• “MGMT for pt mgmt”: Is Methylguanine-DNA Methyltransferase Testing Ready for Patient Management?
  著者:: Iafrate, A. John, 等
  出版事項: (2008)
• Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression
  著者:: Zhu, Zhongling, 等
  出版事項: (2016)
• Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O(6)-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
  著者:: Bush, Zachary M., 等
  出版事項: (2010)